| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1111894093 |
| P356 | DOI | 10.1186/S13643-019-0953-4 |
| P932 | PMC publication ID | 6359805 |
| P698 | PubMed publication ID | 30711016 |
| P50 | author | Joanna Bielecki | Q58416921 |
| Lusine Abrahamyan | Q87257110 | ||
| Murray Krahn | Q41896189 | ||
| Morgan Slater | Q57071082 | ||
| P2093 | author name string | William Wong | |
| Susanna Mak | |||
| George Tomlinson | |||
| Douglas Lee | |||
| Shelley Zieroth | |||
| Heather Ross | |||
| Jane MacIver | |||
| Valeria E Rac | |||
| Ana Carolina Alba | |||
| P2860 | cites work | Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement | Q21195843 |
| Clinical service organisation for heart failure | Q24200713 | ||
| Developing and evaluating complex interventions: the new Medical Research Council guidance | Q24647443 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines | Q26864648 | ||
| The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860537 | ||
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
| Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation | Q29615706 | ||
| Combination of direct and indirect evidence in mixed treatment comparisons | Q29619499 | ||
| The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials | Q29619501 | ||
| Framework for design and evaluation of complex interventions to improve health | Q29619503 | ||
| GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias) | Q29619791 | ||
| The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. | Q30358659 | ||
| Specialized multi-disciplinary heart failure clinics in Ontario, Canada: an environmental scan | Q30528623 | ||
| The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs | Q33916607 | ||
| Simultaneous comparison of multiple treatments: combining direct and indirect evidence. | Q34081552 | ||
| Systematic review of multidisciplinary interventions in heart failure. | Q35584426 | ||
| Heart Failure Management Programmes in Europe | Q57315301 | ||
| 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure | Q57629858 | ||
| Cost-Effectiveness of Specialized Multidisciplinary Heart Failure Clinics in Ontario, Canada | Q57688523 | ||
| Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis | Q81296809 | ||
| US government kicks off program for comparative effectiveness research | Q82564314 | ||
| Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials | Q43102818 | ||
| Assessing the burden of hospitalized and community-care heart failure in Canada | Q43637573 | ||
| Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission | Q44648492 | ||
| The growing burden of perioperative heart failure. | Q44870569 | ||
| Developing and evaluating complex interventions: reflections on the 2008 MRC guidance. | Q46024894 | ||
| Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial | Q46656836 | ||
| Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. | Q46894544 | ||
| Factors affecting uptake of childhood immunisation: a Bayesian synthesis of qualitative and quantitative evidence. | Q52028008 | ||
| Borrowing strength from external trials in a meta-analysis. | Q52287071 | ||
| How to use an article reporting a multiple treatment comparison meta-analysis. | Q53106594 | ||
| GRADE guidelines 6. Rating the quality of evidence—imprecision | Q57269328 | ||
| Referral and use of heart failure clinics: what factors are related to use? | Q35828261 | ||
| Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. | Q35863540 | ||
| Economic burden of heart failure: a summary of recent literature | Q35982912 | ||
| Heart failure disease management: implementation and outcomes | Q36232854 | ||
| Bayesian methods for evidence synthesis in cost-effectiveness analysis | Q36381197 | ||
| Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management | Q36383373 | ||
| A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure | Q36585531 | ||
| Treating the right patient at the right time: access to heart failure care | Q36921035 | ||
| Evaluation of networks of randomized trials | Q36966424 | ||
| Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment | Q36991744 | ||
| The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis | Q37306238 | ||
| ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions | Q37335426 | ||
| Cochrane methods--twenty years experience in developing systematic review methods | Q37360581 | ||
| Meta-analysis: pitfalls and hints | Q37403724 | ||
| Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease | Q37405745 | ||
| Heart failure burden and therapy | Q37622587 | ||
| Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. | Q37888895 | ||
| GRADE guidelines: 9. Rating up the quality of evidence | Q37908614 | ||
| GRADE guidelines: 8. Rating the quality of evidence--indirectness | Q37908616 | ||
| GRADE guidelines: 5. Rating the quality of evidence--publication bias | Q37908618 | ||
| GRADE guidelines: 7. Rating the quality of evidence--inconsistency | Q37908778 | ||
| Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. | Q37996688 | ||
| Specialist clinics for reducing emergency admissions in patients with heart failure: a systematic review and meta-analysis of randomised controlled trials | Q38077175 | ||
| Demystifying trial networks and network meta-analysis | Q38106916 | ||
| The annual global economic burden of heart failure | Q38176481 | ||
| Heart failure clinics are still useful (more than ever?). | Q38182261 | ||
| Mortality risk among sulfonylureas: a systematic review and network meta-analysis | Q38281461 | ||
| Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients | Q38379946 | ||
| Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials. | Q38380479 | ||
| Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). | Q38392232 | ||
| Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study | Q38483735 | ||
| The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations | Q38510678 | ||
| The epidemiology of heart failure: the Framingham Study | Q38512101 | ||
| The attractiveness of network meta-analysis: a comprehensive systematic and narrative review | Q38544308 | ||
| Multidisciplinary management of chronic heart failure: principles and future trends. | Q38594277 | ||
| Detecting outlying trials in network meta-analysis. | Q41103546 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 40 | |
| P577 | publication date | 2019-02-02 | |
| P1433 | published in | Systematic Reviews | Q18216009 |
| P1476 | title | Comparative effectiveness of the different components of care provided in heart failure clinics-protocol for a systematic review and network meta-analysis | |
| P478 | volume | 8 |
| Q90225035 | The Role of Ambulatory Heart Failure Clinics to Avoid Heart Failure Admissions | cites work | P2860 |
Search more.